SV
Surendar Velagapuri
About Surendar Velagapuri
Data last updated:
Surendar Velagapuri has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Hts Biopharma Private Limited and Synventia Pharma Private Limited. Formerly with 1 company, such as Trackversa Mobile Applications Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹8.09 Cr; the largest is Hts Biopharma Private Limited at ₹6.71 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Jan 2017 | 2012 | ₹6.71 Cr (FY 2024) | Active | |
| Director | 28 Oct 2020 | 2020 | ₹1.38 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 May 2017 | 2009 | ₹2.7 Lakh (FY 2018) | Under Process Of Striking Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surendar Velagapuri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surendar Velagapuri
Surendar Velagapuri has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Hts Biopharma Private Limited and Synventia Pharma Private Limited. Formerly with 1 company, such as Trackversa Mobile Applications Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹8.09 Cr; the largest is Hts Biopharma Private Limited at ₹6.71 Cr (FY 2024).
Surendar Velagapuri is associated with 2 companies as Director, including Hts Biopharma Private Limited (₹6.71 Cr), Synventia Pharma Private Limited (₹1.38 Cr).
Surendar Velagapuri has expertise in General Business.
Surendar Velagapuri has 9 years in corporate governance.
By reported revenue, the largest current company of Surendar Velagapuri is Hts Biopharma Private Limited, with revenue of ₹6.71 Cr (FY 2024).
The 2 current companies of Surendar Velagapuri that report revenue have a combined latest revenue of ₹8.09 Cr.
Surendar Velagapuri currently holds positions at 2 companies: Hts Biopharma Private Limited (₹6.71 Cr), Synventia Pharma Private Limited (₹1.38 Cr).